| Crystal structure of the β2 adrenergic receptor–Gs protein complex SGF Rasmussen, BT DeVree, Y Zou, AC Kruse, KY Chung, TS Kobilka, ... Nature 477 (7366), 549-555, 2011 | 3480 | 2011 |
| Structure of a nanobody-stabilized active state of the β2 adrenoceptor SGF Rasmussen, HJ Choi, JJ Fung, E Pardon, P Casarosa, PS Chae, ... Nature 469 (7329), 175-180, 2011 | 2010 | 2011 |
| Structure and function of an irreversible agonist-β2 adrenoceptor complex DM Rosenbaum, C Zhang, JA Lyons, R Holl, D Aragao, DH Arlow, ... Nature 469 (7329), 236-240, 2011 | 905 | 2011 |
| Conformational changes in the G protein Gs induced by the β2 adrenergic receptor KY Chung, SGF Rasmussen, T Liu, S Li, BT DeVree, PS Chae, D Calinski, ... Nature 477 (7366), 611-615, 2011 | 428 | 2011 |
| The effect of ligand efficacy on the formation and stability of a GPCR-G protein complex XJ Yao, G Vélez Ruiz, MR Whorton, SGF Rasmussen, BT DeVree, ... Proceedings of the National Academy of Sciences 106 (23), 9501-9506, 2009 | 296 | 2009 |
| Structural flexibility of the Gαs α-helical domain in the β2-adrenoceptor Gs complex GH Westfield, SGF Rasmussen, M Su, S Dutta, BT DeVree, KY Chung, ... Proceedings of the National Academy of Sciences 108 (38), 16086-16091, 2011 | 280 | 2011 |
| Allosteric coupling from G protein to the agonist-binding pocket in GPCRs BT DeVree, JP Mahoney, GA Vélez-Ruiz, SGF Rasmussen, AJ Kuszak, ... Nature 535 (7610), 182-186, 2016 | 269 | 2016 |
| Pharmacological chaperone for α-crystallin partially restores transparency in cataract models LN Makley, KA McMenimen, BT DeVree, JW Goldman, BN McGlasson, ... Science 350 (6261), 674-677, 2015 | 254 | 2015 |
| Ligand‐regulated oligomerization of β2‐adrenoceptors in a model lipid bilayer JJ Fung, X Deupi, L Pardo, XJ Yao, GA Velez‐Ruiz, BT DeVree, ... The EMBO journal 28 (21), 3315-3328, 2009 | 221 | 2009 |
| Detection of G protein-selective G protein-coupled receptor (GPCR) conformations in live cells RU Malik, M Ritt, BT DeVree, RR Neubig, RK Sunahara, ... Journal of Biological Chemistry 288 (24), 17167-17178, 2013 | 84 | 2013 |
| Current and future advances in fluorescence-based visualization of plant cell wall components and cell wall biosynthetic machineries BT DeVree, LM Steiner, S Głazowska, F Ruhnow, K Herburger, S Persson, ... Biotechnology for Biofuels 14 (1), 78, 2021 | 55 | 2021 |
| Calcium-dependent ligand binding and G-protein signaling of family B GPCR parathyroid hormone 1 receptor purified in nanodiscs N Mitra, Y Liu, J Liu, E Serebryany, V Mooney, BT DeVree, RK Sunahara, ... ACS chemical biology 8 (3), 617-625, 2013 | 52 | 2013 |
| Purification of family BG protein-coupled receptors using nanodiscs: Application to human glucagon-like peptide-1 receptor Y Cai, Y Liu, KJ Culhane, BT DeVree, Y Yang, RK Sunahara, ECY Yan PLoS One 12 (6), e0179568, 2017 | 28 | 2017 |
| Novel fluorescent ligands enable single-molecule localization microscopy of the dopamine transporter DA Guthrie, C Klein Herenbrink, MD Lycas, T Ku, A Bonifazi, BT DeVree, ... ACS chemical neuroscience 11 (20), 3288-3300, 2020 | 12 | 2020 |
| Pharmacological Characterization of Purified Full-Length Dopamine Transporter from Drosophila melanogaster CF Pugh, BT DeVree, SG Schmidt, CJ Loland Cells 11 (23), 3811, 2022 | 2 | 2022 |
| Compounds and prodrugs thereof for the treatment of ophthalmic disease JE Gestwicki, K McMenimen, B DeVree, L Makley US Patent App. 16/588,956, 2020 | | 2020 |
| High throughput methods, protein inhibitors, and uses thereof K McMenimen, JE Gestwicki, B DeVree, L Makley US Patent App. 16/586,479, 2020 | | 2020 |
| Non-surgical method of treatment for cataract JE Gestwicki, K McMenimen, B DeVree, L Makley US Patent App. 16/036,375, 2018 | | 2018 |
| Localization Microscopy Theory and Practice for Data Analysis on Sparsely Labeled Samples BT DeVree, SL Veatch Biophysical Journal 112 (3), 141a, 2017 | | 2017 |
| Structural Basis for Allosteric Coupling Between G Protein and the Agonist‐Binding Pocket in GPCRs J Mahoney, B DeVree, G Velez‐Ruiz, S Rasmussen, A Kuszak, E Edwald, ... The FASEB Journal 30, 931.1-931.1, 2016 | | 2016 |
